Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

6-trifluoromethyl-2-thiouracil possesses anti-Toxoplasma gondii effect in vitro and in vivo with low hepatotoxicity.

Choi HJ, Yu ST, Lee KI, Choi JK, Chang BY, Kim SY, Ko MH, Song HO, Park H.

Exp Parasitol. 2014 Aug;143:24-9. doi: 10.1016/j.exppara.2014.05.002. Epub 2014 May 14.

PMID:
24830752
2.

Toxoplasma gondii: a simple high-throughput assay for drug screening in vitro.

Jin C, Kaewintajuk K, Jiang J, Jeong W, Kamata M, Kim HS, Wataya Y, Park H.

Exp Parasitol. 2009 Feb;121(2):132-6. doi: 10.1016/j.exppara.2008.10.006. Epub 2008 Oct 17.

PMID:
18977350
3.

In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.

Yeo SJ, Jin C, Kim S, Park H.

Korean J Parasitol. 2016 Apr;54(2):155-61. doi: 10.3347/kjp.2016.54.2.155. Epub 2016 Apr 30.

4.

Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo.

Zhou Y, Fomovska A, Muench S, Lai BS, Mui E, McLeod R.

Antimicrob Agents Chemother. 2014;58(3):1789-92. doi: 10.1128/AAC.02225-13. Epub 2013 Dec 23.

5.

Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.

Zhang X, Jin L, Cui Z, Zhang C, Wu X, Park H, Quan H, Jin C.

Exp Parasitol. 2016 Jun;165:95-102. doi: 10.1016/j.exppara.2016.03.020. Epub 2016 Mar 16.

PMID:
26993085
6.

Evaluation of anti-coccidial effects of 1-[4-(4-nitrophenoxy)phenyl]propane-1-one and identification of its potential target proteins in Toxoplasma gondii.

Choi HJ, Lee JH, Yeo SJ, Kaewintajuk K, Yi KY, Kim S, Song HO, Park H.

Arch Pharm Res. 2015;38(5):752-60. doi: 10.1007/s12272-014-0400-y. Epub 2014 May 15.

PMID:
24824336
7.

Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.

Mitchell SM, Zajac AM, Davis WL, Lindsay DS.

J Parasitol. 2004 Jun;90(3):639-42.

PMID:
15270113
8.

Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.

de Oliveira TC, Silva DA, Rostkowska C, Béla SR, Ferro EA, Magalhães PM, Mineo JR.

Exp Parasitol. 2009 Jul;122(3):233-41. doi: 10.1016/j.exppara.2009.04.010. Epub 2009 Apr 21.

PMID:
19389400
9.

Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro.

Galván-Ramírez Mde L, Dueñas Jiménez JM, Rocío Rodríguez Pérez L, Troyo-Sanroman R, Ramírez-Herrera M, García-Iglesias T.

Arch Med Res. 2013 Aug;44(6):415-21. doi: 10.1016/j.arcmed.2013.07.002. Epub 2013 Aug 22.

PMID:
23973195
10.

Neospora caninum and Toxoplasma gondii: relationship between hepatic lesions, cytological and biochemical analysis of the cavitary liquid during the acute phase of the diseases in experimental models.

Bottari NB, Tonin AA, Fighera R, Flores MM, França RT, Camillo G, Toscan G, Vogel FS, Sangoi MB, Bochi GV, Moresco RN, Lopes ST, Da Silva AS.

Exp Parasitol. 2014 Jan;136:68-73. doi: 10.1016/j.exppara.2013.11.004. Epub 2013 Nov 22.

PMID:
24275558
11.

Anti-toxoplasmosis effects of oleuropein isolated from Fraxinus rhychophylla.

Jiang JH, Jin CM, Kim YC, Kim HS, Park WC, Park H.

Biol Pharm Bull. 2008 Dec;31(12):2273-6.

12.

Chitosan and silver nanoparticles: promising anti-toxoplasma agents.

Gaafar MR, Mady RF, Diab RG, Shalaby TI.

Exp Parasitol. 2014 Aug;143:30-8. doi: 10.1016/j.exppara.2014.05.005. Epub 2014 May 19.

PMID:
24852215
13.

Hepatotoxic effect of 1-bromopropane and its conjugation with glutathione in male ICR mice.

Lee SK, Jo SW, Jeon TW, Jun IH, Jin CH, Kim GH, Lee DJ, Kim TO, Lee ES, Jeong TC.

Arch Pharm Res. 2005 Oct;28(10):1177-82.

PMID:
16276976
14.

Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.

El-Zawawy LA, El-Said D, Mossallam SF, Ramadan HS, Younis SS.

Exp Parasitol. 2015 Feb;149:54-64. doi: 10.1016/j.exppara.2014.12.007. Epub 2014 Dec 9.

PMID:
25499511
15.
16.

Antioxidant and hepatoprotective activity of Fagonia schweinfurthii (Hadidi) Hadidi extract in carbon tetrachloride induced hepatotoxicity in HepG2 cell line and rats.

Pareek A, Godavarthi A, Issarani R, Nagori BP.

J Ethnopharmacol. 2013 Dec 12;150(3):973-81. doi: 10.1016/j.jep.2013.09.048. Epub 2013 Oct 17.

PMID:
24140589
18.

Effect of Nigella sativa oil on experimental toxoplasmosis.

Mady RF, El-Hadidy W, Elachy S.

Parasitol Res. 2016 Jan;115(1):379-90. doi: 10.1007/s00436-015-4759-6. Epub 2015 Oct 7.

PMID:
26446086
19.

Hepatoprotective effect of the ethanol extract of Vitis thunbergii on carbon tetrachloride-induced acute hepatotoxicity in rats through anti-oxidative activities.

Deng JS, Chang YC, Wen CL, Liao JC, Hou WC, Amagaya S, Huang SS, Huang GJ.

J Ethnopharmacol. 2012 Aug 1;142(3):795-803. doi: 10.1016/j.jep.2012.06.003. Epub 2012 Jun 12.

PMID:
22698911
20.

Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.

Lindsay DS, Kaur T, Mitchell SM, Goodwin DG, Strobl J, Dubey JP.

J Parasitol. 2005 Dec;91(6):1488-90.

PMID:
16544426
Items per page

Supplemental Content

Write to the Help Desk